Endorobotics
- Company typePrivate
- Founded2016
- HeadquartersSeoul, South Korea
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Endorobotics firmographics
Firmographics- Name
- Endorobotics
- Legal name
- EndoRobotics Co., LTD.
- Website
- https://endorobo.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Endorobotics industry classification
Industry- Product category
- Surgical Robotics / Endoscopic Surgical Robots
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN), Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)
Keywords
Where Endorobotics is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
Endorobotics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Robotic Endoscopic Devices and Systems: EndoRobotics generates revenue through the sale and distribution of robotic-assisted endoscopic technologies including the Robopera system console, articulated grippers, and scope-mounted traction devices. With the Olympus distribution partnership, the company is expanding globally into the endoscopic robotic devices market.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
Endorobotics product offering
Product offeringCore offering
EndoRobotics develops and manufactures robotic-assisted endoscopic surgical devices for minimally invasive gastrointestinal procedures. Its flagship Robopera system uses proprietary micro cable control technology to deliver 720-degree rotation within a 15mm throat diameter and operates as a detachable robot that transforms existing commercial diagnostic endoscopes into surgical instruments. Supporting accessories (TraCloser traction device, RollingStitch suturing instrument, EndoCubot therapeutic device) address endoscopic submucosal dissection (ESD), endoscopic sleeve gastroplasty (ESG), endoscopic mucosal resection (EMR), and endoscopic stitching procedures.
Product overview
Endorobotics develops robotic-assisted endoscopic surgical devices for minimally invasive gastrointestinal procedures. The core product is the Robopera system, a flexible surgical robot compatible with commercial endoscopes that transforms diagnostic tools into surgical instruments. Supporting products include TraCloser (traction device), RollingStitch (suturing device), and EndoCubot for various therapeutic applications. The company focuses on non-resection endoscopic procedures including Endoscopic Submucosal Dissection (ESD), Endoscopic Sleeve Gastroplasty (ESG), endoscopic stitching, and Endoscopic Mucosal Resection (EMR). EndoRobotics has established a global distribution partnership with Olympus Corporation to expand its robotic-assisted endoscopic technologies worldwide, starting with the U.S. market.
Differentiator
Problem solved
Functional benefit
Brands
- RoSE Platform: World's first flexible surgical robot compatible with commercial endoscopes that can be attached to diagnostic endoscopes to transform them into surgical instruments.
- Robopera
- TraCloser
- RollingStitch
- EndoCubot
Products and services
- Robopera Endoscopic Surgery Robot FDA-cleared endoscopic surgery robot using proprietary micro cable control technology to deliver 720-degree rotation within a 15mm throat diameter. It is a detachable device that retrofits onto existing commercial diagnostic endoscopes, transforming them into surgical instruments for advanced gastrointestinal procedures such as ESD, EMR, ESG, and endoscopic stitching. Targeted at hospitals, gastroenterology departments, and endoscopists performing minimally invasive GI procedures.
- TraCloser Endoscopic traction device for complex therapeutic procedures, designed to enhance visualization and tissue manipulation during advanced endoscopic interventions such as ESD and EMR. Used by gastroenterologists and endoscopists performing minimally invasive GI procedures.
- RollingStitch Endoscopic stitching instrument for closing defects, perforations, or incisions during procedures such as ESD or EMR. Enables suture placement through a flexible endoscope to manage complications or achieve complete closure after lesion removal. Targeted at gastroenterologists performing advanced endoscopic procedures.
- EndoCubot Endoscopic robotic device for therapeutic interventions in the gastrointestinal tract, used by endoscopists performing minimally invasive procedures.
Quantifiable outcome
- Robotic-assisted ESD procedures expected to address approximately 900,000 annual deaths from colorectal cancer globally (second leading cause of cancer deaths)
Companies that use Endorobotics
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
Endorobotics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Endorobotics partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Olympus CorporationcoreOlympus signed an exclusive global distribution agreement with EndoRobotics to add robot-assisted technologies to its EndoTherapy portfolio. The partnership combines Olympus' global commercial reach with EndoRobotics' development capabilities to advance therapeutic endoscopy capabilities worldwide, beginning with the U.S. market. The collaboration aims to expand patient access to advanced endoscopic procedures like ESD for treating early-stage cancers and precancerous lesions of the GI tract.
- KIST Hongneung Science ParkminorEndoRobotics was featured as a representative startup by KIST Hongneung Science Park at the pre-IPO PLAZA conference in the deep tech field, highlighting the company's status as a promising technology startup in South Korea's science park ecosystem.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Endorobotics competitors and assessment
Company assessmentBroad incumbents
- Intuitive Surgical: Dominant surgical robotics incumbent behind the da Vinci platform; while focused on laparoscopic soft-tissue surgery, it is the benchmark incumbent EndoRobotics must position against as it expands robot-assisted endoscopy globally.
- Medtronic: Diversified medical device giant that has launched the Hugo robotic-assisted surgery platform; broad incumbent competing across multiple specialties and capable of leveraging its installed base and capital to out-execute niche robotics challengers.
- Johnson & Johnson MedTech: Owner of the MONARCH bronchoscopy robot and Ottava soft-tissue robotics platform under development; broad incumbent with the capital, clinical-trial infrastructure, and channel to compete across EndoRobotics's target indications.
- Boston Scientific: Major player in GI endoscopy tools (including hemostasis, resection, and suturing devices) with growing interest in robotic endoscopy; comparable as a broad incumbent selling adjacent therapeutic accessories into the same hospital call point.
Direct peers
- EndoQuest Robotics: U.S.-based developer of a flexible robotic endoscopy system targeting upper and lower GI procedures; the closest direct competitor to EndoRobotics given overlapping flexible endoscopic robotics focus and similar indication set.
- Medicaroid: Japanese surgical robotics company (backed by Sysmex and Kawasaki Heavy Industries) behind the Hinotori system; highly comparable as an Asian-origin surgical robotics challenger pursuing global hospital accounts with a similar go-to-market profile.
- Asensus Surgical: U.S. company behind the Senhance surgical system, a digital laparoscopic platform targeting general surgery; comparable as a publicly-listed surgical robotics challenger working to gain share against da Vinci with a differentiated architecture.
- CMR Surgical: UK-based developer of the Versius portable surgical robot for minimal-access surgery; comparable as a venture-backed soft-tissue robotics peer pursuing global commercialization with a modular design philosophy similar in spirit to EndoRobotics's detachable approach.
Others
- Olympus Corporation: EndoRobotics's exclusive global distribution partner and the dominant player in flexible endoscopy; listed here because Olympus is simultaneously a channel partner and a potential competitor with internal robotics programs and the Swan EndoSurgical JV.
Emerging players
- Virtual Incision: U.S. surgical robotics startup developing miniaturized robotic-assisted platforms for laparoscopic procedures; comparable as an emerging surgical robotics peer targeting similar minimally invasive indication spaces with a capital-efficient design approach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Endorobotics social profiles
Digital presenceEndorobotics compliance and trust
Trust signalCompliance1 record
Endorobotics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Endorobotics leadership team
Management profileNumber of profiles
Profiles3 records
Endorobotics funding detail
Funding detailFunding overview
Funding rounds7 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Endorobotics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Endorobotics
What does Endorobotics do?
EndoRobotics develops and manufactures robotic-assisted endoscopic surgical devices for minimally invasive gastrointestinal procedures. Its flagship Robopera system uses proprietary micro cable control technology to deliver 720-degree rotation within a 15mm throat diameter and operates as a detachable robot that transforms existing commercial diagnostic endoscopes into surgical instruments. Supporting accessories (TraCloser traction device, RollingStitch suturing instrument, EndoCubot therapeutic device) address endoscopic submucosal dissection (ESD), endoscopic sleeve gastroplasty (ESG), endoscopic mucosal resection (EMR), and endoscopic stitching procedures.
Is Endorobotics a public or private company?
Endorobotics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Endorobotics founded?
Endorobotics was founded in 2016. It employs 11 to 50 people.
Where is Endorobotics based?
Endorobotics is headquartered in Seoul, South Korea, in the Asia region.
How does Endorobotics make money?
One revenue line is on record: robotic Endoscopic Devices and Systems.
Who are Endorobotics's main competitors?
Broad incumbents on record are Intuitive Surgical, Medtronic, Johnson & Johnson MedTech and Boston Scientific. Direct peers are EndoQuest Robotics, Medicaroid, Asensus Surgical and CMR Surgical. Olympus Corporation is listed as an others. Virtual Incision is listed as an emerging player.
Does Endorobotics have an API?
No public API is recorded for Endorobotics.
What industry is Endorobotics in?
Endorobotics's product category is Surgical Robotics / Endoscopic Surgical Robots. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 339112 and its SIC code is 3841.